leisure time -WSS

leisure time

author：fashion 2025-09-30 18:17:18 - browse：566

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： A public scorecard can help hold safety

knowledge

Wikipedia

entertainment

WSS

Custom gene therapy hints at new path for rare disease treatments

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Doctors find melanoma drugs effective against rare brain cancer

Risky weight loss products often used by teens globally, per study

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

focus

leisure time

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New England Journal of Medicine addresses racist history, slavery

George Santos makes 1st court appearance after pleading not guilty to 13 counts

As digital health tech proliferates, a new institute aims to cut through hype

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Affirmative action in medical school literally saved lives

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Supreme Court strikes down use of affirmative action

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

focus

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Heart disease and mental health: A look at cardiac psychology

Doulas covered by Medicaid under New York's new plan

Caregivers of transplant patients call for more support, training

At Orexo, a ‘turning point’ for everything but digital health

JPM 2024: Verve Therapeutics looks to mainstream genome editing

knowledge

Wikipedia

entertainment

explore